Intracoronary Pharmacotherapy (Verapamil-Epinephrine-Adenosine) for Prevention of No Reflow during Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocar
Last updated: 05 Jan 2025
10.21608/bjas.2023.224991.1213
Verapamil-Epinephrine-Adenosine Intracoronary Pharmacotherapy, No reflow, Primary percutaneous coronary intervention, ST elevation myocardial infarction
Ahmed
Bendary
Cardiovascular Medicine, Faculty of Medicine, Benha University
ahmedbendary55@gmail.com
Mohamed
Salem
Cardiovascular Medicine, Faculty of Medicine, Benha University
mohamedabdo88@gmail.com
Amr
El-Sayed
Cardiovascular Medicine, Faculty of Medicine, Benha University
amrabdel-mordy@gmail.com
Haitham
Al-Kady
Cardiovascular Medicine, Faculty of Medicine, Benha University
haithamal-kady@gmail.com
Ayman
Khamis
Cardiovascular Medicine, Faculty of Medicine, Benha University
aymanhazem1994@gmail.com
Cairo
Hany
Ebaid
Cardiovascular Medicine, Faculty of Medicine, Benha University
hanyebaid@gmail.com
8
8
43071
2023-08-01
2023-08-03
2023-08-29
1
11
2356-9751
2356-976X
https://bjas.journals.ekb.eg/article_326334.html
https://bjas.journals.ekb.eg/service?article_code=326334
1
Original Research Papers
1,647
Journal
Benha Journal of Applied Sciences
https://bjas.journals.ekb.eg/
Intracoronary Pharmacotherapy (Verapamil-Epinephrine-Adenosine) for Prevention of No Reflow during Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocar
Details
Type
Article
Created At
28 Dec 2024